Western blot, Immunofluorescence (IF) and immunohistochemistry (IHC) staining further demonstrated significant upregulation of STING pathway expression and reduced tumor proliferation following D166 treatment (Figure 3D-F, Figure S3A). Here, STING1 is linked to neoplasm.